Scot-tussin Original Multi-symptom Cold And Allergy Relief
NDC Package 15187-004-04
Package Information
Scot-tussin Original Multi-symptom Cold And Allergy Relief is do not use more than directed – see Liver warning.follow Dosage Chart.do not take more than 4 doses in any 24 hour period.this product is not intended for use in children under 12 years of age. agedoseAdults and children over 12 years old2 teaspoons (2 tsp. Marketed by Irisys, Llc, this product is identified by NDC 15187-004 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1367384 - acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution
- RxCUI: 1367384 - acetaminophen 32 MG/ML / pheniramine maleate 0.8 MG/ML / phenylephrine hydrochloride 0.8 MG/ML Oral Solution
- RxCUI: 1367384 - acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG per 5 ML Oral Solution
- RxCUI: 1367384 - APAP 32 MG/ML / Pheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 0.8 MG/ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 15187 - Irisys, Llc
- 15187-004 - Scot-tussin Original Multi-symptom Cold And Allergy Relief
- 15187-004-04 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
- 15187-004 - Scot-tussin Original Multi-symptom Cold And Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 15187-004-04 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Scot-tussin Original Multi-symptom Cold And Allergy Relief, labeled by Irisys, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Irisys, Llc on January 01, 2016. The current certification is valid through December 31, 2019.
How is this Irisys, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 15187000404. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.